Acquired myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction
in which patients experience fluctuating skeletal muscle weakness that often affects selected …

Myasthenia gravis (MG) is an autoimmune syndrome caused by the failure of neuromuscular
transmission, which results from the binding of autoantibodies to proteins involved in …

Previous studies have reported alterations in numbers or function of regulatory T (Treg) cells
in myasthenia gravis (MG) patients, but published results have been inconsistent, likely due …

The nicotinic acetylcholine receptors (AChR) are presently the best-characterized
neurotransmitter receptors. They are pentamers of homologous or identical subunits …

Forkhead box P3 (FOXP3) is a transcription factor necessary for the function of regulatory T
cells (Treg cells). Treg cells maintain immune homeostasis and self‐tolerance and play an …

Myasthenia gravis (MG) is an autoimmune disease associated with the production of
autoantibodies against 1) the skeletal muscle acetylcholine receptor; 2) muscle-specific …

Myasthenia gravis (MG) is an autoimmune disorder caused, in most cases, by
autoantibodies against components of the neuromuscular junction, frequently the …

Muscle specific tyrosine kinase myasthenia gravis (MuSK MG) is a form of autoimmune MG
that predominantly affects women and has unique clinical features, including prominent …

Although human and experimental acquired myasthenia gravis (MG) are prototypic antibody
(Ab)‐mediated autoimmune diseases, synthesis of the pathogenic anti‐acetylcholine …

Background/Aims: Autoimmune myasthenia gravis (MG) is a disorder of the neuromuscular
junction caused in the majority of patients by autoantibodies directed against the …